A Fool's Verdict on 5 FTSE Boardrooms
LONDON -- Management can make all the difference to a company's success and thus to its share price.
The best companies are those run by talented and experienced leaders with strong vested interests in the success of the business, held in check by a board with sound financial and business acumen. On the other hand, some of the worst investments to hold are those run by executives collecting fat rewards as the underlying business goes to pot.
In recent weeks, I've assessed the boardrooms of five companies within the FTSE 100: Barclays (ISE: BARC.L) , BP (ISE: BP.L) , GlaxoSmithKline (ISE: GSK.L) , G4S (ISE: GFS.L) and Shell (ISE: RDSB.L) . Today I am going to summarize what I found:
I analyze management teams from five different angles, and give them a score out of 5 for each. That makes a maximum overall score of 25. Here's my assessment of the five boardrooms:
The first company to have the honor of topping the leaderboard is pharmaceutical giant GSK. Ex-Vodafone CEO Christopher Gent chairs a board that is bursting with experience, and CEO Andrew Witty has made impressive strides to enhance the company's reputation with shareholders and the general public. And with 17 million pounds worth of shares, he has put his money where his mouth is.
BP's board scores rather better than rival Shell's. Dealmaker Robert Dudley leads a team of executive directors with impressive industry credentials, though the chairman seems a little lightweight for the political pressures that BP has to contend with. With so much at stake in Russia, it could be an Achilles' heel.
Shell's chairman was the man who turned Nokia from a struggling conglomerate into a mobile-phone giant, but he then stayed in charge as it turned into a struggling mobile-phone company. A reasonably strong board is held back by their reluctance to invest hard cash in the company's shares.
In equal second place is G4S, whose CEO, Nick Buckles, has just been put through the wringer by a parliamentary committee over the Olympics staffing debacle. He didn't perform well, but shareholders benefit more from a CEO who builds a business and its share price, as Buckles has done, than from one who can grandstand and verbally joust as politicians are wont to do.
If he is forced to resign, I would knock a couple of points off G4S' total score. Neil Woodford, star fund manager at Invesco Perpetual, which is G4S' second-largest shareholder, has said, "the interests of shareholders are best served by keeping Nick Buckles, because his track record is excellent." What's more, he and the other executive directors have substantial sums invested in the success of the company.
Barclays erstwhile CEO, Bob Diamond, resigned following an appearance at another parliamentary committee. But his performance was altogether different: smooth, unruffled, but possibly less than frank. He is credited with building up Barclays' investment bank, but the share price has tanked since he became CEO. Barclays' board is overloaded with former investment bankers and without Diamond has little to recommend it.
I've collated all my FTSE 100 boardroom verdicts on this summary page. I hope my research can assist your investment decisions.
Buffett's favorite FTSE share
Let me finish by adding that legendary investor Warren Buffett has always looked for appealing management teams when pinpointing which shares to buy. So I think it's important to tell you that the billionaire stock-picker has recently acquired a substantial stake in a prominent FTSE 100 company.
A special free report from The Motley Fool -- "The One UK Share Warren Buffett Loves" -- explains Buffett's purchase and investing logic in full.
And Buffett, don't forget, rarely invests outside his native United States, which to my mind makes this British blue chip -- and its management -- all the more attractive. So why not download the report today? It's totally free and comes with no further obligation.
Where is the U.K.'s leading dividend stock-picker investing today? The identities of Neil Woodford's favorite blue chips are revealed in this free Motley Fool report -- "8 Shares Held By Britain's Super Investor."
Further Motley Fool investment opportunities
The article A Fool's Verdict on 5 FTSE Boardrooms originally appeared on Fool.com.Tony owns shares in GSK and Shell but no other shares mentioned in this article.The Motley Fool has a disclosure policy.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.